Posted 5 months ago

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 (HARMONi-7)

ClinicalTrials.gov IDNCT06767514

Protocol number SMT112-3007

Sponsor Summit